LINC 2023: Late-breaking Science Video Collection

Published: 20 June 2023

Views:
794
Likes:
7

Views:
794
Likes:
7
Share:

Now Playing
Part 1 | Session 4 of 9
IN.PACT AV ACCESS: Outcomes to Date
Matteo Tozzi

Up Next
8m 14s

Part 1 | Session 5 TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes
Koen Deloose
7m 13s

Part 1 | Session 6 POPCORN Registry: DCB Treatment for Peripheral Artery Disease
Yoshimitsu Soga
3m 49s

Part 1 | Session 7 MOTIV Bioresorbable Scaffold in BTK Lesions
Michel Bosiers
6m 6s

Part 1 | Session 8 Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK
Marc Sirvent
8m 56s

Part 1 | Session 9 LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions
Sahil Parikh

5m 2s

Part 1 | Session 1 AVPAS: Lutonix AV Post-Approval Study Scott O Trerotola

5m 18s

Part 1 | Session 2 The ELEGANCE Registry: Ranger DCB In Under-Represented Groups Marianne Brodmann

4m 51s

Part 1 | Session 3 RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety Marianne Brodmann

Average (ratings)

No ratings

Your rating

Overview

Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

Expert Interviews

Short, accessible Expert Interviews with select faculty focusing on the results, applicability, and impact on future research.

9 sessions
AVPAS: Lutonix AV Post-Approval Study	Watch now
The ELEGANCE Registry: Ranger DCB In Under-Represented Groups	Watch now
RANGER II SFA: 3 Year Patency and 4 Year Clinical Safety	Watch now
IN.PACT AV ACCESS: Outcomes to Date	Watch now
TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes	Watch now
POPCORN Registry: DCB Treatment for Peripheral Artery Disease	Watch now
MOTIV Bioresorbable Scaffold in BTK Lesions	Watch now
Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK	Watch now
LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions	Watch now

About the episode

LINC 23 - Join us as we delve into the findings of the IN.PACT AV Access study with Dr Matteo Tozzi (University of Insurbia, IT).

Sponsored by Medtronic, the IN.PACT AV Access study aimed to compare the efficacy of the IN.PACT AV™ drug-coated balloon with standard percutaneous transluminal angioplasty in patients with de novo or non-stented lesions of the arteriovenous fistula (AVF). A total of 330 patients were enrolled in this trial.

Questions:

Please remind us of the reasoning behind the IN.PACT AV ACCESS Trial.
What are the study design and patient cohort?
What are the key findings revealed at LINC 23?
Are there any patient cohorts that could benefit more from the use of this DCB?
How should these findings impact practice?
What are the next steps?

Recorded remotely from Varese, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent

Faculty Biographies

Matteo Tozzi

University of Insurbia, Varese, IT

View full profile

Comments

You must be to comment. If you are not registered, you can register here.